l.wikstrom
TL2 · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 20 February 2025 · last posted 17h
83Posts here
1Topics
1Solutions
723Likes received
451Likes given
21Badges
196Days visited
3.5kPosts read
Recent activity
Full stream-
How shortages have affected compounding permissions — does this still hold? Replied, post #32 · Access › Shortages · 27 Jul 2026 · 18 likes Trying to state the shortages position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
-
Insomnia at a dose step: reported experiences — the long version Replied, post #52 · Wellbeing › Sleep · 27 Jul 2026 · 0 likes Coming back to post #48, because the follow-up matters more than the original answer. Sleep quality changes reported here have several plausible contributors, and…
-
What a good consultation looks like from the other side Replied, post #61 · Clinical › Prescriber conversations · 21 Jul 2026 · 3 likes Post #59 is right about the mechanism and I think understates the practical bit. One more thing on good consultation that took me far too long to see: the two figures…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #50 · Start Here › Welcome · 16 Jul 2026 · 18 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #43 · Compounds › Retatrutide · 14 Jul 2026 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
How much context is too much context in a first post? Replied, post #72 · Start Here › How to Ask · 10 Jul 2026 · 15 likes I read post #70 twice before replying, because I had assumed the opposite. Disagreement-style questions: "I read this and it contradicts what I heard here, which is…
-
Insurance and replacement policies, compared Replied, post #71 · Sourcing › Logistics · 7 Jul 2026 · 10 likes Worth separating two things that post #69 runs together. Worth stating the null on insurance and replacement policies before we explain it: the observation may be…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #40 · Compounds › Retatrutide · 5 Jul 2026 · 7 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #2 · Analytics › COA interpretation · 2 Jul 2026 · 9 likes Nobody has said the unglamorous part of Batch date yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Second pass at: When your prescriber and the evidence disagree Replied, post #42 · Clinical › Prescriber conversations · 28 Jun 2026 · 4 likes Agreed on all of that, and I have nothing to add to it.
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #35 · Pharmacology › Pharmacokinetics · 27 Jun 2026 · 6 likes Post #33 is right about the mechanism and I think understates the practical bit. Area under the curve is the exposure measure that matters for most effects in this…
-
Osteoarthritis and mechanical versus metabolic improvement Replied, post #4 · Clinical › Comorbidities · 26 Jun 2026 · 9 likes My experience of osteoarthritis and mechanical versus metabolic contradicts the reply above. I am posting it as a data point rather than as a refutation, because one…